News

09 Sep 2014

Minapharm's Subsidiary, ProBioGen, celebrates the 20th anniversary: €20 million investment in Mammalian Manufacturing Expansion

On the occasion of its 20th anniversary,ProBioGen AG announced to invest 20€ million and to double its workforce. CEO Dr. Wieland Wolf welcomed scientific, business and political guests in a ceremony in Berlin on September 4, 2014..

» More
27 Nov 2012

VTU Technology, Austria and Minapharm Pharmaceuticals S.A.E., Egypt enter into development and license agreement

VTU Technology, Austria and Minapharm Pharmaceuticals S.A.E., Egypt enter into development and license agreement.

» More
16 Jun 2010

Minapharm Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO

ProBioGen AG announced that Minapharm Pharmaceuticals, Cairo, has completed the acquisition of 95 % of the share capital of ProBioGen.

» More